SHIM
GMED icon

Stone House Investment Management’s Globus Medical GMED Stock Holding History

Stone House Investment Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237 Buy
+3
New +$255 ﹤0.01% 1175

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Stone House Investment Management's GMED Position: Q2 2026 in Review

Stone House Investment Management opened a new position in Globus Medical (GMED) in Q2 2026: 3 shares worth $237. The stake represents ﹤0.01% of the portfolio and ranks #1175 among its holdings.

597 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Stone House Investment Management held 3 shares of Globus Medical worth $237 as of Q2 2026.
  • Globus Medical was a new Stone House Investment Management position in Q2 2026.
  • Globus Medical made up ﹤0.01% of Stone House Investment Management's portfolio in Q2 2026, its #1175 holding.
  • 597 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.